Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
But if we only consider ‘the published literature’ to be that indexed in bibliographic databases, then we may be missing useful ‘published’ literature about drug hazards from national databases of spontaneous adverse drug reaction reports.
Re: Study results show it’s time to rethink systematic review methods
I agree there’s a substantial problem.
But if we only consider ‘the published literature’ to be that indexed in bibliographic databases, then we may be missing useful ‘published’ literature about drug hazards from national databases of spontaneous adverse drug reaction reports.
There is information from:
Australia in the database of adverse drug event notifications at http://www.tga.gov.au/DAEN/daen-entry.aspx
UK Public Assessment Reports at http://www.mhra.gov.uk/Publications/PublicAssessmentReports/index.htm
Drug Analysis Prints from http://www.mhra.gov.uk/
Canadian Adverse Reaction Database at http://www.hc-sc.gc.ca/
New Zealand’s suspected medicines adverse reaction search at
http://www.medsafe.govt.nz
where there are links to other European and American resources.
Competing interests: No competing interests